🎁 Black Friday: up to 50% off of annual plans
Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.560
-0.270 (-5.59%)
At close: Nov 20, 2026, 4:00 PM EST
4.749
+0.189 (4.15%)
After-hours: Nov 20, 2026, 7:30 PM EST

Strata Critical Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-24.8141.35-27.31-56.08-27.26-36.92
Depreciation & Amortization
21.96.93.267.115.731.17
Loss (Gain) From Sale of Assets
----0.07-
Asset Writedown & Restructuring Costs
7.432.715.7620.75--
Loss (Gain) From Sale of Investments
1.285.2--2.16-
Stock-Based Compensation
20.3817.8319.8912.58.2811.28
Provision & Write-off of Bad Debts
---0.16--
Other Operating Activities
-4.5-58.11-3.82-10.06-26.095.4
Change in Accounts Receivable
-2.64-12.03-1-10.25-5.35-1.74
Change in Accounts Payable
-8.612.38-8.349.059.92.52
Change in Unearned Revenue
0.071.68-0.120.120.741.56
Change in Other Net Operating Assets
-3.55-1.116.45-5.65-5.31-4.9
Operating Cash Flow
10.72-48.91-2.52-32.35-37.13-21.63
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.92-9.6-30.86-2.11-0.73-0.49
Sale of Property, Plant & Equipment
---0.14--
Cash Acquisitions
-37.18-66.54-2.23--48.1-23.07
Divestitures
-1.86-2.81----
Sale (Purchase) of Intangibles
-1.19-1.42-2.12---12.36
Investment in Securities
62.72150.1134.219.06128.17-280.26
Investing Cash Flow
12.5769.75-1.0217.0979.34-316.17

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt Repaid
------1.17
Net Debt Issued (Repaid)
------1.17
Issuance of Common Stock
0.110.190.170.070.09335.04
Repurchase of Common Stock
-10.67-9.11-5.93-0.15-1.17-3.17
Financing Cash Flow
-10.91-8.91-5.76-0.08-1.08330.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
--0.34-0.08-0.070.07-0.01
Net Cash Flow
12.3911.59-9.37-15.441.2-7.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
0.81-58.51-33.38-34.46-37.86-22.12
Free Cash Flow Growth
------
Free Cash Flow Margin
0.29%-29.68%-22.74%-15.30%-25.91%-32.93%
Free Cash Flow Per Share
0.01-0.71-0.43-0.47-0.53-0.41
Levered Free Cash Flow
2.2-26.98-28.89-11.67-18.34-
Unlevered Free Cash Flow
2.2-26.98-28.89-11.67-18.34-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.650.09-0.02--
Change in Working Capital
-14.72-9.08-3.01-6.74-0.02-2.56
SEC Filings: 10-K · 10-Q